Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. - Wikidata - awgldk - TriplyDB

Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings.

Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings.

http://www.wikidata.org/entity/Q37351394

about

Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers Efficacy of single dose Nevirapine in reducing viral load in HIV positive mother in labour and transmission of HIV infection to new born babies as part of prevention of parent to child transmission.Prevention of mother-to-child transmission of HIV: treatment options.Controversies in the use of nevirapine for prevention of mother-to-child transmission of HIV.Influence of body mass index on pregnancy outcomes among HIV-infected and HIV-uninfected Zambian women.Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia Acceptance of HIV testing among women attending antenatal care in south-western Uganda: risk factors and reasons for test refusal.Field performance of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood.

P2860

Q33497614-99B56A51-C8D2-4532-AAF5-791EC35B33ED Q34466893-D8DBD192-DACA-4918-858A-112BD851AADE Q36322136-1B55C01E-B6CC-4E44-BF59-DC1BD584FA0B Q36429712-A4E8A437-1307-4DC8-8E1B-6838782BC28D Q36943530-1D5BF79B-723D-45EB-BFB9-121E24224577 Q37349292-424FA4F8-A845-46FE-B05A-135029A06224 Q38876072-57B45077-1476-4D14-B4DB-259D370CFD61 Q46913600-41E92B7D-0314-4B4A-84EE-18D3161B8A14

P2860

Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings.

http://www.wikidata.org/entity/Q37351394

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Universal nevirapine upon pres ...... n in high prevalence settings.

@en

Universal nevirapine upon pres ...... n in high prevalence settings.

@nl

type

label

Universal nevirapine upon pres ...... n in high prevalence settings.

@en

Universal nevirapine upon pres ...... n in high prevalence settings.

@nl

prefLabel

Universal nevirapine upon pres ...... n in high prevalence settings.

@en

Universal nevirapine upon pres ...... n in high prevalence settings.

@nl

P1433

Q37351394-21510B66-4117-4C80-A8DB-EE3C6F12273A

P1476

Q37351394-D8FC1D11-19E2-4C08-9BD2-B5B63AE7894B

P2093

Q37351394-427E9C3A-D655-4E46-A903-407B22339328

Q37351394-A36EC4B7-2C31-452F-B2CA-1FDA5EE2251A

Q37351394-ACAF6843-68EC-467D-9B9C-15C6437A35B3

Q37351394-FE9B0F11-373C-4E92-A51E-BE2DDAE47D15

P2860

Q37351394-059BA394-2258-42ED-AE61-407DFC85F69B

Q37351394-0AD75CC7-2F15-47FA-9A1E-64D0F2D226CF

Q37351394-0E5DD8FF-8DCB-47F1-89F1-210B830C6D5F

Q37351394-25B1ABD1-C4A5-4EBA-909D-52035CDFBE38

Q37351394-42437C0A-206C-4BA4-899B-E4C94A6EF799

Q37351394-6DED51F7-C398-4135-B9BC-C37B51853B0A

Q37351394-86C90342-5887-4AED-AD36-793DF5175A5B

Q37351394-F3C1E775-E9D6-41E3-8BEE-F4CD7AC05701

Q37351394-FA9BB080-AD03-4E08-9F34-A3D2667FCB1C

P304

Q37351394-C5EBB18A-A925-444D-9C0A-FFBF1D23DAE7

P31

Q37351394-F4231AF5-FE79-4D2D-8539-43474767D150

P356

Q37351394-43446D3E-E15B-44FA-8569-03E00AF625EB

P407

Q37351394-D4E25B5F-C487-48F4-BCDE-ACDD2A0D6DB0

P433

Q37351394-906B149D-BDA1-45BB-BF2F-B9E68F613C8E

P478

Q37351394-AB24BE4E-7768-43D3-8D53-C1E5CD6610B9

P50

Q37351394-45EEED5E-84C1-4C3C-BB76-DAEDCD69C2C6

Q37351394-9772EF3E-2F13-4DB6-A207-FD815FC8363F

Q37351394-AA6351F3-466F-4586-827E-707E5904D9C2

Q37351394-CECCA269-C7AE-404B-BD55-4EA7C401C251

P577

Q37351394-AB07731D-C4DB-46D7-9B4D-86156395BE6C

P5875

Q37351394-376EFF31-C7DB-4CBB-A755-32AC24622FA0

P698

Q37351394-2A126730-649C-4081-8D8F-50FAD411C411

P921

Q37351394-67D0F566-9524-460D-860C-AE6297A96DF1

P932

Q37351394-7214CF99-1C34-402E-BBB6-CEDB850D22AB

P356

00002030-200404090-00012

P1433

P1476

Universal nevirapine upon pres ...... n in high prevalence settings.

@en

P2093

Edward P Acosta

http://www.w3.org/2001/XMLSchema#string

Grace M Aldrovandi

http://www.w3.org/2001/XMLSchema#string

Jeffrey S A Stringer

http://www.w3.org/2001/XMLSchema#string

Rosemary Kumwenda

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine.

Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia.

Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa.

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

P304

939-943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00002030-200404090-00012

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Robert L Goldenberg

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8641835

http://www.w3.org/2001/XMLSchema#string

P698

15060442

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

P932

2745979

http://www.w3.org/2001/XMLSchema#string